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Abstract
Breathing must be regulated to maintain appropriate levels of oxygen and carbon 
dioxide. Breathing may be influenced by serotonergic (5-HT) neurons, sensitive to CO2, 
which activate the brain’s respiratory network. However, this role of 5-HT neurons as 
C0 2 -sensitive chemoreceptors in unanesthetized animals is unclear. This study used an 
unanesthetized in situ perfused rat brainstem preparation to test the hypothesis that 5-HT 
neurons contribute to CO2 ventilatory responses. Changes in phrenic nerve discharge 
patterns were monitored as gas-saturated solutions supplying the preparation were 
switched from 5%CC>2 to IV0CO2 (balance O2). The importance of 5-HT neurons was 
identified by comparing responses before and after application of the specific serotonin 
1A receptor agonist 8 -hydroxy-(dipropylamino) tetralin hydrobromide (8 -OH-DPAT; at 
doses of 0,1.5, 3, and 6  uM in the perfusate). The action of 8 -OH-DPAT is to inhibit 5- 
HT neurons and reduce synaptic 5-HT release. Results indicated that changes in phrenic 
burst pattern similar to hypercapnic ventilatory responses observed in vivo, were greatly 
disrupted by 8 -OH-DPAT treatment. These results illustrate that activation of 5-HT 
neurons is critical for CO2 chemosensitivity in this in situ preparation and suggest that 
these neurons may play a key role in the regulation of breathing in otherwise intact 
animals.
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1.0 Neural Control of Breathing
Respiration is a vital, complex process and must be regulated with precision. It 
facilitates oxygenation of the body’s tissues, elimination of CO2, and the associated acid- 
base balance that is necessary for homeostasis in aerobic organisms (von Euler 1986). 
Chemical homeostasis involves a delicate balance between CO2, O2 and pH levels.
When respiration is inadequate, CO2 accumulates. Extreme excesses of CO2 molecules 
result in dangerously acidic pH levels (H2O + CO2 <-> H2CO3 «-► H+ + HCO3”), and at low 
pH levels (high [H+]) the respiratory center in the medulla becomes stimulated to change 
ventilation appropriately (Remmers 1999). It is important to keep CO2 levels within a 
very narrow range, as even small changes in the concentration of protons in the blood 
(less than 0.1 uM) can be fatal (Richerson 2004). In order to maintain pH within 
physiological limits there are neurons in the brainstem that monitor the levels of CO2 via 
changes in pH. These neurons transfer information about CO2 to the respiratory network, 
where breathing is adjusted accordingly (Feldman et al. 2003, Richerson 2004).
The neural network that controls ventilation (the respiratory network) has a 
hierarchical organization with voluntary and involuntary components, including 
respiratory sensors, controllers and effectors. Regulation of CO2, O2 and pH is 
accomplished by the respiratory musculature whose activities are controlled by the 
central nervous system (Feldman and McCrimmon 1999). This activity is further 
modulated by peripheral input from various sensory neurons which are important in 
maintaining chemical homeostasis, such as the pulmonary stretch receptors in the lungs 
(Harris 2003) and chemoreceptors in the carotid bodies (Day 2005). Changes in
breathing are primarily autonomic: the respiratory network monitors CO2 and O2 and 
responds appropriately.
Ventilation of the lungs is central to respiration, as eliminating CO2 from the 
blood helps increase the pH of blood. Intercostal and diaphragm muscles actively 
contract to pull 0 2 -laden air into the lungs, and gas exchange occurs when inhaled O2 
passes into tiny alveoli in the lungs and diffuses through pulmonary capillaries into 
arterial blood. CO2 diffuses in the opposite direction, from capillary blood to the alveoli, 
reducing blood pH The diaphragm relaxes on exhalation, in conjunction with elastic 
recoil of the chest and, in some cases, contraction of abdominal muscles, and C0 2 -laden 
air is forced out of the lungs. It is a perpetual, dynamic, rhythmic process that normally 
proceeds smoothly and subconsciously.
Although rhythmic and continual, respiration is not always steady; it exhibits 
considerable plasticity, which matches breathing to metabolic demands (Mitchell and 
Johnson 2000). In the face of long term physiological changes like development, aging, 
pregnancy, changes in weight, and brain injury, the brain can make precise adjustments to 
preserve adequate respiration. Respiration also changes almost immediately with 
changes that increase or decrease O2 consumption: exercise, posture, sleep state, massive 
blood loss, and intensely emotional situations result in changes in the breathing pattern 
(Kestin 1992). Respiration remains constantly responsive to challenges affecting O2, pH, 
and CO2 (Feldman et al 2003). Although mainly under subconscious control, respiration 
can also be changed voluntary. It is an incessant and precise cycle.
1.1 Respiratory pattern generation
Respiration normally occurs in an automatic, rhythmic cycle . The respiratory 
network is active from birth until death, without significant pause. The involuntary 
control center of respiration is located in the brainstem, particularly in the medulla and 
pons. This rhythmically active network regulates the cycle of inspiration and expiration. 
The network is driven by central chemoreceptors and other sources of tonic input, like 
stretch receptors in the lungs and peripheral chemoreceptors (Feldman et al. 2003). As it 
attempts to maintain an appropriate balance of O2 and CO2, the respiratory network 
serves as a kind of metronome, providing directions to motor neurons innervating the 
respiratory muscles, resulting in muscle movements necessary for inspiration and 
expiration. Although the respiratory rhythm can be generated in the absence of afferent 
fibers (von Euler 1986), peripheral input helps to ensure that the rhythm is 
physiologically appropriate. Exactly how the network is organized and what mechanisms 
underlie rhythmogenesis are topics of debate.
The respiratory network must monitor dynamic levels of O2 and CO2 (via related 
changes in pH) and adjust breathing appropriately (von Euler 1986). Since the 
respiratory centers in the medulla and pons have no, or inadequate, sensitivity to pH on 
their own (Nattie and Li 2001; Feldman and Del Negro 2003), they must use 
chemosensitive neurons of the respiratory network to sense changes in pH (Nattie 1999). 
Afferent inputs provide chemical information to the network, which integrates the 
information and produces appropriate respiratory outputs that match ventilation to
metabolic demands (McCrimmon et al. 1995). It is vital to define which 
neurotransmitters may be responsible for modulating the respiratory network.
Two major areas of the brainstem have been identified which may contribute to 
the rhythm of respiration: the pre-inspiratory area (prel) in the retrotrapezoid nucleus/ 
parafacial respiratory group and the pre-Botzinger complex (Feldman and Del Negro 
2006). The prel area contains neurons known to fire immediately before and after the 
inspiratory burst, and they retain rhythmic activity in the presence of synaptic blockade 
and in the absence of high potassium (Onimaru et al. 1990). The preBotzinger nucleus is 
proposed as the site where respiratory rhythm is generated (Smith et al. 1991), and 
preBotz neurons likely work in concert with prel neurons to produce the respiratory 
rhythm in intact mammals (see Feldman and Del Negro 2006, Wilson et a l 2006, for 
review). Although it is widely accepted that rhythm generators like the prel and the 
preBotzinger exist in the respiratory network, details of their locations and interactions 
are unclear and were not an integral part of this study. However, it was relevant to 
consider what inputs, if any, may ultimately be affecting the rhythm-generating neurons. 
Wang et al. (2002) found that lesioning neurons in the respiratory complex results in 
inappropriate responses to CO2. Although the respiratory network produces a regular 
breathing rhythm, tonic inputs may also be required to maintain adequate respiration. 
Sources of tonic drive include chemoreceptors, state dependence/higher brain centers, 
and O2- sensitive inputs from carotid bodies. In addition to these, breathing can be 
controlled voluntarily by the forebrain (McCrimmon 1995). This fusion of inputs results 
in a process with a variety of influences, difficult to tease out experimentally.
Experiments using isolated or transected brainstems, while valuable in isolating rhythmic 
neurons, may remove natural tonic inputs (Wilson et al. 2006). Experiments using 
anesthetized animals retain the tonic network but respiration may be affected by 
anesthesia (Kestin 1992). It seems, therefore, that an extremely useful experimental 
model would be the intact, unanesthetized brainstem. The perfused rat brainstem used 
for this study includes the respiratory network, including sources of tonic drive, and 
exhibits respiratory patterns and ventilatory reflexes resembling those of intact animals 
(Paton 1996, St. John and Paton 2000).
1.2 Neuromodulation and chemosensitivity
Neuromodulation allows the nervous system to adapt its control of physiological 
functions to a changing environment. Neuromodulation is the process by which 
neurotransmitters or other substances are released into broad regions of the nervous 
system and have an effect on entire populations of neurons downstream. This is more 
efficient, but less precise, than a typical synaptic connection where one presynaptic 
neuron communicates with one postsynaptic neuron. For example, neurons near the 
bloodstream can sense changes in arterial blood pH and immediately convey this 
information to hundreds or thousands of efferent neurons in the respiratory network that 
can influence ventilation (Richerson 2004). Neuropeptides, biogenic amines, and 
neurotransmitters like acetylcholine, dopamine, serotonin and histamine are all capable of 
modulation (Katz and Frost, 1996). Serotonin (5-hydroxytryptamine, 5-HT) may play a 
role in the modulation of breathing (Bradley et al. 2002, Feldman et al. 2003, Onimaru et
al. 1998, Pena and Ramirez 2002). For example, application of specific serotonin 
receptor ligands exerts an excitatory effect on respiratory activity both in vitro (Onimaru 
et al. 1998) and in vivo (Lalley et al. 1994, Cayetanot et al. 2002). This study focuses on 
serotonergic neurons (neurons which secrete serotonin) and their role as neuromodulators 
of the respiratory network.
Neurons that can detect CO2 or pH are classified as chemoreceptors. Respiratory 
chemoreceptors are cells that possess an intrinsic sensitivity to pH and/or CO2, as well as 
anatomical connections in the central nervous system that enable them to modulate the 
respiratory network (Guyenet et al. 2005). In this manner, chemoreceptors in the 
respiratory network provide the chemical drive to change breathing in response to 
changing O2 and CO2 levels. There are two types of chemoreceptors: “central” 
chemoreceptors are located in the brainstem and respond to arterial Pco2 via extracellular 
pH (Eldridge 1984) or intracellular pH, and “peripheral” chemoreceptors in the carotid 
bodies that respond to arterial Pco2 in a P0 2- and glucose-dependent manner (Feldman et 
al. 2003, Richerson, 2004; Putnam et al. 2004). The network of rhythmic respiratory 
neurons relies mainly on central chemoreceptors, which may have excitatory or inhibitory 
effects, along with other sources of excitatory drive (Feldman et al. 2003). The way in 
which chemosensitive neurons integrate at the cellular and network levels is uncertain 
(Feldman et al. 2003), and the details of how they modulate respiration are also under 
investigation (Richerson 2004, Guyenet et al. 2005).
Recently, great progress has been made towards identifying specific neuronal 
types which may be central chemoreceptors. These include serotonergic neurons of the
midline raphe (Richerson 2004), serotonergic neurons in the medulla with adjacent 
neurons that express neurokinin-1 (Nattie et al. 2004), glutamatergic neurons of the 
retrotrapezoid nucleus (Mulkey et al. 2004), and noradrenergic neurons of the locus 
coeruleus (Putnam et al. 2004). There are also other neurons without known 
neurotransmitter content that may act as central chemoreceptors; for example, neurons in 
the nucleus tractus solitarius, preBotzinger complex, hypothalamus and cerebellum 
(Richerson 1998; Feldman et al. 2003, Putnam et al. 2004). Although the existence of 
central pH/CC>2 chemoreception is widely recognized, neither the neuron type 
(serotonergic, glutamatergic, noradrenergic, etc.) nor the precise location of the central 
chemoreceptors has been definitively established (for review, see Guyenet 2005 and 
Richerson 2005). The evidence, however, supports the role of serotonergic neurons of 
the midbrain in central respiratory chemoreception.
1.3 Serotonergic neurons and chemosensitivity
Serotonin (5-HT) is a monoaminergic neurotransmitter that is made in neuronal 
cell bodies in the central nervous system and in enterochromaffin cells in the 
gastrointestinal tract (Richter 2003). In the brain, it has enormous influence over a 
variety of functions, including motor activity, cognition, mood, arousal, breathing, and 
cardiovascular function. Serotonin is synthesized from the amino acid L-tryptophan for 
release into the synapse, where it binds to 5-HT receptors on the postsynaptic neuron and 
presynaptic cell body (Richter et al. 2003). At least 15 5-HT receptor subtypes have been 
identified, and the majority of these act as slow, G-protein-linked receptors, through
second messenger systems and adenylate cyclase (Barnes and Sharp, 1999). Specific 
serotonin receptor subtypes have been implicated in various disorders, including 
schizophrenia, depression, anxiety, obsessive compulsive disorder, and migraine. The 
physiological function of each receptor subtype has not been established and is still under 
investigation. (The 5-HTiA receptor family in the raphe nuclei has been implicated in 
respiration, and is discussed in further detail in Section 1.4). Serotonergic activity in the 
synapse is terminated when serotonin molecules are recycled by the serotonin transporter 
(SERT) or degraded into metabolic byproducts by monoamine oxidases (Pauwels 1997).
Serotonergic neurons in the medulla may have a role as central respiratory 
chemoreceptors (Wang et al. 2002, Bradley et al. 2002), because of their 
chemosensitivity and occurrence in regions known to influence breathing (Richerson 
2004). According to Richerson (1998), Putnam et al. (2004), and Guyenet et al. (2005), 
pH and/or CO2 chemoreceptor candidates must meet two criteria: they must possess 
intrinsic chemosensitivity to physiologically relevant changes in pH/CC>2, and they must 
have the capability to appropriately affect respiratory output. Serotonergic neurons meet 
both criteria (Richerson 2004).
1.3.1 Chemosensitivity of serotonergic neurons
Acidification of serotonergic neurons in brain tissue slices, neuron culture, and in 
vivo preparations induces changes in their firing rates, and reveals their intrinsic 
chemosensitivity, as demonstrated in the following examples. Wang et al. (1998) 
showed that cells of the rat medullary raphe are stimulated by an increase in CO2,
increasing their firing rate threefold in response to an increase Pco2 from 5% to 9% (CO2 
levels within normal physiological limits). Later, it was found that a majority of 
serotonergic neurons (7 3 %) in rat medulla tissue culture are highly chemosensitive to 
physiologically relevant changes in pH, and the same response occurs in isolated rat 
medullary slices (Wang et al. 2001). Cellular responsiveness persists following blockade 
of glutamate and GAB A, indicating that chemosensitivity in serotonergic neurons is 
independent of input from glutamatergic neurons and GABA-ergic neurons in both tissue 
cultures and medullary slices, and is thus an intrinsic property of the cell (Richerson 
1995; Wang and Richerson, 1999; Bradley et al. 2002). In fact, the intrinsic 
chemosensitivity of serotonergic neurons has been found to be greater than that observed 
for the other chemoreceptor candidates (Putnam et al. 2004). There is some evidence that 
serotonergic neurons also demonstrate chemosensitivity in vivo. A group of serotonergic 
neurons in the medulla of awake, behaving cats increase their firing rate by 160% in 
response to inhalation of 8 % CO2 (Veasey et al. 1995). When rat medullary raphe 
neurons are exposed to focal acidification in vivo, ventilation increases (Bernard et 
al. 1996). It should be noted that although it is likely that chemosensitive neurons are 
sensitive to changes in pH and stimulate breathing, they also might be inhibited by 
acidosis and in turn release respiratory output from tonic inhibition (Wang et al. 2 0 0 1 ). 
Whatever the mechanism, a large number of experiments have revealed the 
chemosensitive nature of serotonergic neurons. As such it is proposed that serotonergic 
neurons possess biologically important chemosensitivity both in vitro and in vivo 
(Richerson et al 2001).
The aforementioned studies demonstrated that serotonergic neurons may play a 
role in sensing changes in pH. However, it must be noted that “central” chemoreceptors 
can have diverse and wide-ranging effects, not just modulation of breathing.
Serotonergic neurons may have an impact on other systems, like cerebrovascular control 
(Underwood et al. 1995, Cohen et al. 1996), arousal (Saper et al. 2001), and anxiety 
(Hendricks 2003). Richerson (2004) suggested that the serotonin system plays a global 
role in controlling pH homeostasis, motor control, and neural tissue homeostasis. 
Maintaining adequate ventilation is a small part of maintaining homeostasis, but a vital 
role nonetheless. Researchers have therefore focused on defining how serotonin is linked 
to ventilation and have found anatomical links that reveal an intimate physical connection 
between serotonergic neurons and the respiratory network (Richerson 2004).
1.3.2 Location
In order for serotonergic neurons to be central chemoreceptors that modulate 
breathing, they must 1) occur in appropriate regions where sensitivity to pH and/or CO2 
is necessary, and 2 ) have appropriate anatomical connections to affect respiratory output. 
Serotonergic neurons are indeed located in an optimal position to monitor blood pH 
levels. They are located in a region of the medulla containing large arteries and few 
veins. Blood within these regions has recently exchanged gas at the lungs and has not 
been greatly influenced by local tissue metabolism. Within these regions, distinct 
populations of serotonergic neurons occur in close proximity to arteries supplying the
brainstem including large branches of the basilar artery (Bradley et al. 2002; Severson et 
al. 2003; Messier et al. 2004). These neurons are proximal to blood vessels, allowing 
them to monitor the acid-base status of blood (Richerson et al. 2002). Serotonergic 
neurons in these positions have been shown to increase their firing rates in response to 
acidosis, as would be expected of a chemoreceptor (Richerson 2004).
1.3.3 Connectivity
If serotonergic neurons are important respiratory chemoreceptors, they must 
somehow influence ventilation after sensing changes in pH or CO2. Serotonergic neurons 
possess the appropriate neuronal connections that would be expected of a chemoreceptor. 
Although not directly responsible for altering homeostatic processes, serotonergic 
neurons project to various regions of the brain that have direct roles in regulating a 
number of homeostatic processes. Serotonergic neurons project to areas of the brain that 
respond to changes in CO2 and regulate a variety of functions, including arousal, anxiety, 
cardiovascular control, neural tissue homeostasis, and motor control. Specifically, 
serotonergic neurons project to medullary respiratory neurons innervating the diaphragm 
(Richerson 2004). Thus, they are able to monitor pH and/or CO2 and transmit this 
information to appropriate targets in the brainstem respiratory network that affect 
breathing accordingly.
1.3.4 Serotonergic neuromodulation
Serotonergic neurons are capable of influencing respiratory patterns. Most 
serotonergic neurons in the brain are located within the midline raphe nuclei (Jacobs and 
Azmitia 1992), and a subset project to medullary respiratory neurons (Richerson 2004). 
This connection enables chemosensitive serotonergic neurons to modify the ventilatory 
pattern in response to changes in pH/CC>2. Several studies have shown that serotonin 
plays a key role in the response to increased CO2; normally, ventilation in rats increases 
in response to induced acidosis in the medullary raphe (Feldman et al. 2003). However, 
Messier et al. (2004) found that selective lesioning of rat serotonergic medullary raphe 
serotonergic neurons decreases the ventilatory response to systemic CO2. Along the 
same lines, destroying serotonergic neurons with saporin conjugated to an antibody to the 
serotonin transporter (SERT) reduced the ventilatory response to CO2 in vivo (Nattie et 
al. 2004; Richerson, 2004). The loss of serotonergic modulation documented in these 
studies resulted in a diminished respiratory response to CO2, implying that serotonin is 
required for an appropriate response to hypercapnia. Many serotonergic neurons are 
located close to penetrating arteries in a position appropriate for monitoring CO2 in blood 
that will supply the central nervous system (Wang et al. 2002). Although not directly 
involved in regulation of respiratory muscles, serotonergic neurons project to a diverse 
array of brainstem and midbrain regions that directly modulate the respiratory network 
(Nattie et al. 2004). These and related studies serve as evidence that a sub-population of 
serotonergic neurons functions as important chemoreceptors.
1.4 5-HT ia receptors
The 5-HTia receptors in areas of the brainstem, such as the midline raphe nuclei, 
that are proposed to act as central chemoreceptors, have been classified as 
somatodendritic autoreceptors occurring on the cell body (for review see Glennon et al. 
2 0 0 0 ). Similar receptors, 5HTib/d, are classified as presynaptic autoreceptors and are 
located on the presynaptic membrane of neurons that synthesize and release serotonin 
(Pauwels 1997). Binding to 5-HTia autoreceptors in the raphe nuclei results in inhibition 
of serotonin neuron activation, while binding to 5HTib/d receptors suppresses release of 
neurotransmitter from the serotonergic neuron. The net result of 5-HT iAandB/D 
autoreceptor binding is a reduction of serotonergic excitation of neurons that receive 
input from serotonin neurons. This study utilized a strong agonist for 5-HT ia and 5- 
HTib/d receptors to reduce or abolish post-synaptic influences, in order to demonstrate 
the role normally served by serotonergic neurotransmission. The prototypical agonist for 
5-HTiAand 5-HTib/d receptors is the 8 -hydroxy-2 -(di-n-propylamino)tetralin (8 -OH- 
DPAT), an aminotetralin derivative that binds 5-HTiA and 5-HTib/d receptors with high 
affinity (EC50 = 6.9, 125nm for 5-HTia, Del Tredici et al. 2004). 8 -OH-DPAT is 
commonly used to reduce or abolish release of serotonin at neuron terminals. Although 
multiple receptor subtypes remain available for binding on postsynaptic neurons, 
administering the selective agonist 8 -OH-DPAT to 5-HTi receptors in the midline raphe 
should bind to presynaptic 5-HTia/b receptors with such an affinity as to be sufficient to 
prevent serotonergic chemoreceptive neurons from signaling (Del Tredici et al. 2004).
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1.5 Chemoreceptor Controversy
In large part, the respiratory network is, by itself, insensitive to changes in pH. 
Despite ample in vitro evidence suggesting that serotonergic neurons could act as central 
chemoreceptors that modulate the respiratory network, there is some dispute about 
whether serotonergic neurons function in vivo as primary central chemoreceptors that 
activate the respiratory network. Guyenet et al. (2005) proposed that glutamatergic 
neurons of the retrotrapezoid nucleus (RTN) have a more robust response to pH than 
other neuron types. Unfortunately, this conclusion was drawn from experiments that 
utilized large changes in pH (7.5 to 6.9) that may not be relevant to the small changes 
typically seen in respiratory control (7.4 to 7.2), as described by Wang et al. (2002) and 
Putnam et al. (2004). Based on observations of anesthetized rats, Guyenet (2004) argued 
that hypercapnia has a marginal stimulatory effect on only a small percentage of 
medullary raphe serotonergic neurons in vivo. However, the “small percentage” of 
serotonergic neurons was actually 2 2 %, and it is possible that a large part of those 
neurons project to respiratory neurons (Richerson 2004).
Based on data derived from anesthetized animals, Guyenet et al. (2005) argued 
that glutamatergic neurons of the retrotrapezoid nucleus are central chemoreceptors and 
serotonergic neurons are not. Guyenet and colleagues cite studies by Veasey et al. (1995) 
and Mulkey et al. (2004) who found that glutamatergic neurons in the ventral medulla 
altered firing rates, when acidified, and that glutamatergic disruptions altered 
chemosensitivity in anesthetized rats, while only a small minority of the serotonergic 
neurons they tested were stimulated when CO2 increased (Mulkey et al. 2004).
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The degree of chemosensitivity is an important factor in determining the 
relevance of a neuron type to respiratory control (Richerson 1998, Putnam et al. 2004, 
Guyenet et al. 2005). RTN neurons have a chemosensitivity index of 200% (Putnam et 
al. 2004) which is indeed larger than some other candidates for respiratory 
chemoreceptors (Putnam et al. 2004) but serotonergic neurons have a chemosensitivity 
index of 300% (Wang et al. 2002; Richerson 2004). Serotonergic neurons cannot be 
discounted in favor of glutamatergic neurons: serotonergic cells demonstrate a robust 
response to physiologically relevant levels changes in pH (Richerson 2004).
Three groups studying chemosensitivity agree that a major criterion for a 
chemoreceptor candidate, besides the degree of chemosensitivity, is that chemosensitivity 
is an intrinsic property (Richerson 1998, Putnam et al. 2004; Guyenet et al. 2005). It has 
not been proven that glutamatergic neurons of the RTN are intrinsically chemosensitive: 
studies by Mulkey et al. (2004) showed that RTN neurons were stimulated by changes in 
pH, but Richerson (2005) argued that the particular in vivo approach could not determine 
whether the response was intrinsic to the RTN cells or synaptically stimulated by other 
cells releasing neurotransmitters that could include serotonin. Glutamatergic neurons 
could not be considered primary chemoreceptors if they rely on phasic synaptic inputs to 
respond to changes in pH. On the other hand, serotonergic neurons have been shown to 
be intrinsically sensitive to changes in pH (Veasey et al. 1995; Wang et al. 1998; Wang 
and Richerson 2000), and, since they are intimately connected to the respiratory network, 
they are superior candidates for central respiratory chemoreceptors (Richerson 2004).
1.6  Hypothesis
Previously, only a small number of recordings had been made from 
unanesthetized, intact animals and only from a restricted subset of serotonergic neurons 
(Richerson 2005). Other research on serotonergic neurons, like the acidification studies 
by Wang et al. (2001), used in vitro or in situ methods, and the function of serotonergic 
neuromodulation in vivo remained unclear. The present study is designed to fill the gap 
and to determine the role of serotonergic neurons in chemosensitivity in an 
unanesthetized in situ preparation believed to exhibit patterns of nerve activity and 
chemosensitivity akin to breathing in vivo.
Serotonergic neurons meet the criteria to be effective chemoreceptors: they are 
sensitive to CO2 in vitro and in vivo, they are located in appropriate anatomical positions 
to sense changes in pH levels, and they are connected to a variety of other brain regions 
that participate in respiratory responses (Richerson 2004). Serotonergic neurons possess 
characteristics in vitro and in vivo that would make them effective chemoreceptors, and 
their role as such was investigated in this project. By inhibiting serotonergic neuronal 
firing via stimulation of the 5-HTi A somatodendritic autoreceptor, the present study 
explored the hypothesis that serotonergic neurons are critical for respiratory 
chemosensitivity.
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Materials and Methods
2.1 Perfused rat brainstem preparation
The perfused rat brainstem preparation has been well characterized and is widely 
accepted as an appropriate tool for studies of the neural control of breathing (Paton 1996; 
St. John and Paton, 2000; Harris and St. John, 2003). The preparation is particularly 
desirable for the proposed investigations as it has many of the advantages of both in vivo 
and in vitro preparations. The preparation is without a cerebrum but otherwise the central 
nervous system is intact (Figure 1). Thus, the entire brainstem respiratory control network 
and associated tonic inputs are in place and not influenced by anesthesia beyond the 
initial dissection (Paton 1996). The preparation exhibits respiratory patterns of discharge 
on nerves innervating respiratory muscles, and it exhibits changes in these patterns 
associated with CO2 exposure, comparable to breathing and ventilatory responses of the 
intact animal (Paton, 1996; St. John and Paton, 2000). Respiratory-modulated neuronal 
activities with discharge patterns similar to those in vivo also can be recorded in the 
medulla and pons and can be maintained for long durations. The preparation facilitates 
specific control of drug concentrations when bath-applied in the perfusate. It preserves a 
stable cardiovascular system during severe manipulations, as aortic perfusion pressures 
and flow may be held constant or regulated as an experimental variable (Paton 1996).
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Figure 1. The perfused rat brainstem preparation, a well-characterized and widely 
accepted model for the neural control of breathing. The portion of the body caudal to the 
diaphragm is removed, and a catheter pumping artificial cerebrospinal fluid is inserted 
into the aorta. The perfusate passes from the reservoir, where it is equilibrated with 
varying levels of O2 and CO2, through a roller pump, filter, and bubble trap while 
perfusing the preparation at a pressure of ~50mmHg. 5% CO2 is considered normocapnia 
and 7% CO2 is hypercapnia. Phrenic activity is monitored by a bipolar electrode 
connected to the phrenic nerve; activity is amplified, filtered, integrated and recorded. 
Phrenic neurograms are recorded by the PowerLab data acquisition system.
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This study employed juvenile male Simonsen S/A albino rats, rattus novegicus 
(Simonson Laboratories, Gilroy, CA). Rats were 24-27 days and weighed 80-120g. At 
this age the response of rats to hypercapnia has reached maturity (Stunden et al. 2001) 
For ease of handling, rats were anesthetized with halothane (2-bromo-2-chloro-1,1,1- 
trifluoroethane) in a glass chamber until unresponsive. Rats were injected with an 
anticoagulant, 1.5ml heparin sodium injection (1000USP, Baxter, Deerfield, IL), and 
allowed to recover from anesthesia. After a fifteen minute period, rats were again 
anesthetized with halothane until spontaneous respiratory movement ceased ( 1 -2  min). 
Following procedures outlined in the original description of this preparation (Paton 1996) 
the skull was opened at the coronal suture and all of the brain rostral to the colliculi 
removed by aspiration. The portion of the body caudal to the diaphragm was removed. 
The temperature of the remaining portion of the body was reduced by immersion in 
chilled artificial cerebrospinal fluid (aCSF; see below). The pelt was removed from the 
torso. The diaphragm was gently separated from the outer body wall using forceps and 
hemostats and the outer body wall was cut away, leaving a 3-4cm length of spinal cord. 
The heart, lungs and diaphragm were left intact. The descending aorta was freed from 
other tissue using hemostats and tweezers, and the end cut cleanly with surgical scissors. 
The right phrenic nerve was isolated and sectioned at the level of the diaphragm and 
attached to a bipolar glass capillary suction electrode.
Rats were positioned supine in a plastic, rectangular tray, and a catheter (French 
double lumen, 1.25mm, Braintree Scientific, Braintree, MA) was inserted into the aorta, 
advanced approximately 2cm rostrally, and tied in place with braided waxed silk (CS
surgical suture). One lumen of the aortic catheter was connected to a peristaltic pump 
delivering aCSF, equilibrated with 95% 0 2 -5 % CO2 and at an initial temperature of 30°C. 
The second lumen of the catheter was used to measure pressure within the aorta, which 
was maintained between 50-70mm Hg by regulating the speed of the perfusion pump. 
Gallamine triethiodide is added to the perfusate to eliminate motor movements (St. John 
and Paton 2000). The temperature of the brainstem was maintained at 29-31°C by 
adjusting the temperature of the perfusate entering the aorta via the heat exchanger 
system, and monitored constantly with a digital thermometer. Although slightly 
hypothermic, this temperature greatly enhanced the viability of the preparation, which, at 
29-31 °C, exhibits phrenic burst pattern frequencies equal to the breathing frequencies of 
hypothermic rats in vivo (St. John and Paton 2000).
The aCSF perfusate contained the following in distilled water (in mM): MgS0 4  
(1), NaH2P0 4 (1.25), KC1 (4), NaHC03 (24), NaCl (115), D-glucose (10), CaCl2 (2), 
Ficoll 70 (0.1785). Ficoll was used as an osmotic agent in perfusate solutions to replace 
non-ionic osmotically active particles, such as proteins. From a reservoir where the 
solution was equilibrated with O2 and CO2, the perfusate passed through a roller pump, 
heat exchanger, filter (Millipore 45uM), a “bubble trap”, and then through the cannula in 
the aorta. There typically were small fluctuations in perfusion pressure (3-5mm Hg) 
resulting from the roller pump. Perfusate leaked from sectioned vessels in the animal and 
collected in a reservoir. The initial 50ml of perfusate was discarded to eliminate blood, 
the rest was recirculated.
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2.2 Recording of neural activity
Phrenic nerve activities were monitored by bipolar electrodes. Glass capillaries 
were pulled to a fine taper and ground back to produce a needle with inner tip diameter of 
30 microns, approximating the diameter of the phrenic nerve. Capillaries were held in a 
micromanipulator (Model KITE-R, WPI, Sarasota, FL) via a suction electrode connector 
(A-M Systems, Sequim, Washington). Perfusion pressure was gradually increased in 
increments of 10mm Hg approximately once every minute until phrenic activity returned 
with a eupneic, ramp-like pattern (Figure 2) (see also St. John and Paton 2000). Phrenic 
activity was monitored by the electrode, amplified (1st stage DAM 50 differential 
amplifier, WPI, Sarasota, FL; 2nd stage Model 5900 Universal amplifier, Gould 
instruments, Cleveland, OH); filtered (0.6-6.0 KHz) and integrated (50ms moving 
average) using full wave rectification (Model, CWE Incorporated, Wood Dale, IL). Raw 
and integrated signals were recorded to a computer data-acquisition system sampling at 
200 Hz (Chart, Version 5.0, PowerLab, ADInstruments, Colorado Springs, CO). An 
oscilloscope and audio monitor were utilized intermittently to assist in the discrimination 
of phrenic burst signals. Data acquisition included tracings of raw and integrated phrenic 
neurograms (Figure 2), as well as continuous pressure and CO2 measurements.
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Figure 2. Steady phrenic neurogram burst pattern during normocapnia (5% CO2). The 
raw phrenic neurogram, above, is integrated using a 50msec time constant and full-wave 
rectification to produce the integrated phrenic neurogram, below. The ramp-like rise of 
integrated activity from the phrenic nerve is consistent with eupnea (“normal breathing”)
in vivo.
Subsequent data analysis was conducted using the integrated signal and the data 
analysis utilities provided by the data acquisition system (PowerLab). Figure 3 illustrates 
the five burst pattern variables quantified from the integrated phrenic neurograms (Chart 
Data Analysis, Version 5.3): burst frequency (Fr), peak height (peak), time of neural 
expiration (period between bursts, Te), time of neural inspiration (burst duration, Ti) and 
area under the burst (area). The burst variables correlate with those measured in the first 
use of the perfused rat brainstem preparation by St. John and Paton (2000): neural 
inspiration corresponds to Ti, neural expiration is Te, Fr is calculated by Ti + Te/ 60 as an 
index of breathing frequency; peak height and area under the burst may serve either as 
indices of tidal volume, or the amount of air inhaled/exhaled, or both (St. John and Paton 
2000). It was important to measure all five variables in the phrenic neurogram as they 
may change individually or in a coordinated manner (St. John and Paton 2000). It was 
unknown at the start of this study whether the inhibition of serotonergic modulation with 
8 -OH-DPAT would manifest as a change in one variable or more than one.
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Figure 3. Phrenic nerve discharge during eupnea (normal breathing). Integrated activity 
of the phrenic nerve was quantified by measuring five burst pattern variables: peak 
height, Ti (time of inspiration), Te (time of expiration, between bursts), area under the 
peak, and burst frequency which is related to breathing frequency. Instantaneous 
frequency of bursts (Fr) was calculated as 60/ (Ti + Te).
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2.3 Protocol
The preparation was allowed an initial equilibration period of at least 40 min, 
after temperature and pressure had equilibrated at appropriate levels (29-31°C, 50-70mm 
Hg). Under initial conditions, the perfusate was equilibrated with 95% O2 -5% CO2 
(physiologically relevant levels of O2 saturation). To mimic normocapnic/hypercapnic 
conditions, levels of O2 and CO2 were altered by changing the concentrations in the 
perfusate using manual gas flow regulators. CO2 concentrations equilibrating with the 
perfusate were constantly monitored with a CO2 gas analyzer (Ametek CD-3 A, Paoli, 
PA). Pilot studies demonstrated that less than 5 min was necessary following a change in 
CO2 levels to allow the perfusate to fully equilibrate and circulate to the experimental 
preparation. As such, measurements of the hypercapnic response were taken only in the 
second 5 min of a 10 min hypercapnic challenge (Figure 4).
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5%C02
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t
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Add 8-OH-DPAT
Figure 4. The experimental protocol. Measurements of the five burst variables were 
measured in the second 5 minutes of each ten minute increment, to allow the perfusate to 
equilibrate with 5% or 7% CO2 during the first five minute increment. Bold lines 
indicate periods during the experiment during which normocapnic and hypercapnic 
responses were recorded. A baseline hypercapnic response in each animal was recorded. 
Doses of 0, 1.5, 3, and 6 uM 8 -OH-DPAT were applied to the perfusate, then the 
preparation was given a second hypercapnic (7 %C0 2 ) challenge and its responses to 
hypercapnia were compared, before and after application of the 5-HTiA agonist 8 -OH- 
DPAT,.
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2.4 Responses to hypercapnia
All preparations were exposed to one hypercapnic challenge to record a baseline 
hypercapnic response. The rats were exposed to hypercapnia by changing gas 
equilibrating in the perfusate from 5% to 7% CO2 . A 5-min period following the change 
in CO2 was allowed for equilibration of the perfusate. The rats were then maintained at 
CO2 of 7% for 5min, after which CO2 was returned to 5%. A period of 1 Omin was 
allowed for re-equilibration between subsequent changes in CO2.
2.5 Responses to hypercapnia following serotonin block
In order to characterize the response of the respiratory system without serotonin 
modulation, 8-Hydroxy-2-(di-n-propylamino) tetralin hydrobromide, (8 -OH-DPAT, 
Aldrich, St. Louis, MO), a high affinity 5-HTia receptor agonist, was added to the 
perfusate. This study focused specifically on the 5-HTja receptor subtype because it 
provided a tool for modification of the serotonergic system by inhibiting the presynaptic 
serotonin neurons. 5-HTia receptors are located primarily on the presynaptic cell soma 
and at the presynaptic cleft. Blockade of these receptors inhibits serotonin synthesis and 
release from the presynaptic neuron (Pauwels 1997). In this way, pharmacological 
activation of 5-HTiA receptors reveals the importance of serotonergic neuromodulation.
After an initial hypercapnic challenge, prior to drug application, the preparation 
was allowed to equilibrate with 5% CO2. 8 -OH-DPAT was added to the perfusate and 
the preparation was again allowed to equilibrate for 1 Omin to ensure sufficient 
equilibration with the 8 -OH-DPAT solution.
After the dose of 8 -OH-DPAT was added into the perfusate reservoir, 10 min 
were allowed for equilibration of 8 -OH-DPAT. Then the CO2 was again increased from 
5% to 7% for 10 min, and then reduced again to 5% for a 10 min recovery period. 8 -OH- 
DPAT was administered in four doses: OuM (sham treatment), 1.5uM, 3uM and 6 uM. 
Doses of OuM provided timed controls, and equivalent volumes of mock aCSF were 
added to the perfusate in place of the pharmacological agent.
2.6 Data analysis
Phrenic neurograms recorded in PowerLab were analyzed using Chart V.5.3 
(PowerLab, ADInstruments). An analysis template program was developed that marked 
burst peaks on the phrenic neurograms and subsequently quantified five variables: Ti, Te, 
area, peak, and frequency (Figure 2). Values for the burst characteristics were 
determined from the integrated activity of the phrenic nerve. These included 
measurements of burst duration (neural inspiration, Ti), the period between bursts (neural 
expiration, Te), the area under the integrated curve of the burst (area), and the peak height 
of the integrated burst (peak). In addition, the instantaneous burst frequency (Fr) was 
calculated for each burst as 60/ (Ti + Te).
The neural ventilatory response to hypercapnia was evaluated at four different 
doses of 8 -OH-DPAT (0, 1.5, 3, 6 uM). The addition of 9uM 8 -OH-DPAT greatly 
disrupted burst pattern, such that burst variables and their change with CO2 exposure 
could not be adequately assessed. Responses were evaluated as the perfusate was 
changed from one equilibrated with 95% 0 2 -5 % CO2 (normocapnia) to one with 93% O2-
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7% CO2 (hypercapnia). The variables were analyzed in four separate periods during each 
experiment: 1 ) 5  min of exposure to normocapnic perfusate immediately prior to 
hypercapnia, 2) 5 min of exposure to hypercapnic perfusate, 3) 5 min of exposure to 
normocapnic perfusate with 8 -OH-DPAT, and 4) 5 min of exposure to hypercapnic 
perfusate with 8 -OH-DPAT. During these four periods, burst pattern variables were 
quantified from the integrated phrenic neurogram. The burst pattern variables were 
assessed during normocapnia (5% CO2) and hypercapnia (7% CO2) to determine any 
changes in the burst characteristics associated with the normal hypercapnic response.
The proportional change in each burst parameter during hypercapnia relative to the value 
during normocapnia was calculated. Values from the five burst variables were recorded 
to the PowerLab DataPad program and subsequently into a formatted Excel spreadsheet 
that quantified the hypercapnic response by calculating a ratio (hypercapnic value/ 
normocapnic value) under baseline conditions and following treatment with sham or 
doses of 8 -OH-DPAT. Relative values equal to 1 are associated with no response, while 
values not equal to 1 represent a reduction or increase in the response to hypercapnia. 
Variables were assessed following 8 -OH-DPAT treatment and compared with pre­
treatment normocapnic values to determine the impact of serotonin neuron inhibition on 
normal burst pattern. Then, any changes in burst characteristics during hypercapnia, and 
the changes in burst pattern between normocapnia and hypercapnia, were compared 
before and after 8 -OH-DPAT treatment to determine the impact of serotonin neuron 
inhibition on hypercapnic burst pattern responses.
Integrated activity of the phrenic nerve was quantified using Ti, Te, area, peak, 
and frequency as described above. Statistical evaluations (Kaleidagraph Version 4.0, 
Synergy Software, Reading, PA) of sham experiments were by the non-parametric Two- 
Way Repeated Measures ANOVA, with time and CO2 level as factors, and post hoc 
analysis Tukey test. The response to hypercapnia and the drug response were evaluated 
using comparison of group means using a One-Way Repeated Measures ANOVA and 
post hoc Tukey test. A Two-Way ANOVA with Student-Neuman-Keuls post hoc 
comparison test was employed to establish whether or not there was a significant 
difference among the different doses of 8-OH-DPAT and whether it would be valid to 
pool across drug doses. Probabilities less than 0.05 were considered significant.
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Results
3.1 Initial conditions
Under normocapnic conditions (5% CO2, prior to 8-OH-DPAT application) 
phrenic burst discharge had a characteristic incrementing profile consistent with previous 
observations (St. John and Paton, 2000). Figures 2 and 3 illustrated representative 
patterns of discharge seen in the phrenic motor output of the preparation (St. John and 
Paton 2000). Phrenic bursts were characterized as a normal breathing (or “eupneic”) 
pattern akin to phrenic discharge during normal spontaneous breathing in vivo (Figure 5). 
Under constant normocapnic conditions (without 8-OH-DPAT) eupneic phrenic burst 
discharge appeared stable over time and comparable between preparations. Time control 
trials confirmed that eupneic burst patterns during normocapnia and hypercapnia would 
remain consistent in preparations for periods in excess of four hours, which was longer 
than the time required for the experimental protocol (about two hours).
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Figure 5. Representative phrenic neurograms from the perfused rat brainstem 
preparation. The neurograms demonstrate phrenic burst discharge under conditions of 
normocapnia (5%C02) and hypercapnia (7% CO2). Note how the frequency of bursts in 
the integrated neurogram (bottom tracing) increases with hypercapnia but the other burst 
characteristics (Ti, Te, peak, area) do not.
On average, under initial conditions of 5% CO2 (n=18), phrenic discharge had a 
Ti of 0.46 ± 0.02s (Figure 6), a Te of 4.05 ± 0.71s (Figure 7), an area of 0.39 ± 0.15V*s 
(Figure 8), and peak of 1.34 ± 0.34V (Figure 9). Bursts occurred with Fr of 22.9 ± 3.01 
bursts per minute (Figure 10).
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Figure 6. Values for the variable Ti (burst duration). Measurements were made under 
normocapnic and hypercapnic conditions, before and after application of the 5HTia 
receptor agonist 8-OH-DPAT. Data are mean ± SE for n=6 preparations.
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Figure 7. Values for the variable Te (neural expiration). Measurements of inter-burst 
pause under normocapnic and hypercapnic conditions, before and after application of the 
5HTia receptor agonist 8-OH-DPAT. Data are mean ± SE for n= 6 preparations.
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Figure 8. Values for the variable area. Measurements were made under normocapnic and 
hypercapnic conditions, before and after application of the 5HTiA receptor agonist 8-OH- 
DPAT. Data are mean ± SE for n= 6 preparations.
37
>
£
a
a>
. c
2s:cc<nCL
3.5
2.5 -
2 -
1.5 -
0.5
5% C02, Pre drug 
7% C02, Pre drug 
5% C02, Post drug 
7% C02, Post drug Peak
1.5 3
8-OH-DPAT dose, uM
Figure 9. Values for the variable peak. Measurements of neural burst peak were made 
under normocapnic and hypercapnic conditions, before and after application of the 5HT ia 
receptor agonist 8-OH-DPAT. Data are mean ± SE for n= 6 preparations.
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Figure 10. Values for the variable frequency (Fr). Instantaneous frequency of neural 
bursts was measured under normocapnic and hypercapnic conditions, before and after 
each application of the 5HTi a receptor agonist 8-OH-DPAT. Data are mean ± SE for n 
6 preparations.
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3.2 Hypercapnic response
During hypercapnia (7% CO2, prior to 8-OH-DPAT application) phrenic 
discharge had an average (n=18) Ti of 0.41 ± 0.04s (Figure 6), Te of 2.21 ± 0.24s (Figure 
7), an area under integrated burst of 0.32 ± 0.17V*s (Figure 8), and peak of 1.23 ± 0.33V 
(Figure 9). Bursts occurred with frequency of 26.9 ± 4.3 bursts per minute (Figure 10).
To quantify the hypercapnic response (before 8-OH-DPAT), burst variables were 
compared between periods of exposure to 5% and 7% CO2 and expressed as a ratio (value 
at 7%/ value at 5%). These proportional values demonstrated the degree of change in the 
burst pattern following a hypercapnic challenge (a value of 1 indicates no change, a value 
greater than 1 indicates an increase in the quantity of the variable as CO2 increased, and a 
value less than 1 indicates a decrease in the quantity of the variable as CO2 increased).
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Figure 11. The relative change in the duration of the burst (Ti), with hypercapnia and 
drug. Measurements were made following an increase from 5% to 7% CO2, pre- and 
post- treatment with doses of 5HTi a agonist 8-OH-DPAT. Data are mean ± SE for n-6  
preparations. A value of 1 implies no change, while values greater than 1 show an 
increase in Ti and less than 1 show a relative decrease in Ti. There is no statistically 
significant difference in Ti (p=l .0) during the normal hypercapnic response. The burst 
duration response did not significantly change after treatment with 8-OH-DPAT
(p=0.821).
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Figure 12. The relative change in the time between bursts (Te) with hypercapnia and 
drug. Measurements were made following an increase from 5% to 7% CO2, pre- and 
post-treatment with 5HTia agonist 8-OH-DPAT. Data are mean ± SE for n=6 
preparations. A value of 1 implies no change, while values greater than 1 show an 
increase in Te and less than 1 show a relative decrease in Te. There was a statistically 
significant reduction in Te (p=<0.001) during the normal hypercapnic response. There 
was not a statistically significant difference in Te after treatment (p=0.073).
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Figure 13. The relative change in burst area with hypercapnia and drug. Measurements 
were made following an increase from 5% to 7% CO?, pre- and post-treatment with 
5HTia agonist 8-OH-DPAT. Data are mean ± SE for n=6 preparations. There was not a 
statistically significant difference in area (p=0.637) during the hypercapnic response. A 
value of 1 implies no change, while values greater than 1 show an increase in frequency, 
and less than 1 show a relative decrease in frequency.
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Figure 14. The relative change in burst peak with hypercapnia and drug. Measurements 
were made following an increase from 5% to 7% CO2, before and after treatment with 
5HTia agonist 8-OH-DPAT. Data are mean ± SE for n=6 preparations. A value of 1 
implies no change, while values greater than 1 show an increase in peak height and less 
than 1 show a relative decrease in peak. There was no statistically significant difference 
in peak height (p=l .000) during the normal hypercapnic response. The burst peak height 
response was not significantly changed after treatment with 8-OH-DPAT (p=0.272).
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Figure 15. The relative change in burst frequency with hypercapnia and drug. 
Measurements were made following an increase from 5% to 7% CO2, before and after 
treatment with 5HTia agonist 8-OH-DPAT. Data are mean ± SE for n=6 preparations. 
A value of 1 implies no change, while values greater than 1 show an increase in 
frequency, and less than 1 show a relative decrease in frequency. There was a 
statistically significant increase in frequency (p=<0.001) during the normal hypercapnic 
response. The frequency response was significantly reduced (p= 0.018) following 
treatment with 8-OH-DPAT, regardless of dose.
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The only burst variables that changed significantly with hypercapnia were Fr and 
Te. A Repeated Measures ANOVA revealed a statistically significant increase in the 
frequency (Fr) response under hypercapnic conditions (p=<0.001) and a pairwise 
multiple comparison Tukey test confirmed this finding (p<0.05). Using the Repeated 
Measures ANOVA on ranks, with time and CO2 level as factors, also showed a 
significant change in Te (p=<0.001) confirmed by a pairwise multiple comparison 
procedure (Tukey test, (p<0.05). These data indicate that the hypercapnic response was 
mediated by changes in the duration of neural expiration and burst frequency.
3.3 Time controls
There was no time-dependent response to CO2 (St. John and Paton 2000). The 
initial values for a group of animals that received sham drug treatment (n=6) did not 
change significantly over time. Te, peak and area were unchanged. There were no 
significant differences in hypercapnic responses of any burst characteristic between initial 
conditions and following sham treatment. Using a Two-Way Repeated Measures 
ANOVA, values for burst area and burst peak were comparable to those seen in control 
animals (none showed a significant difference before and after CO2 or over time). The 
frequency (Fr) response to hypercapnia was comparable to those seen under initial 
conditions. Frequency changed significantly(p=0.016) with CO2, as expected (St. John 
and Paton 2000) and the frequency response to hypercapnia remained statistically 
unchanged over time (p=0.454), before and after sham treatment. Unlike the trend
demonstrated by the pool of control animals (n=l 8), the values for Te in the smaller 
subset of sham-treated animals (n=5) was not changed with hypercapnia. The values for 
Te did not change significantly with time (p=0.827) or with hypercapnia (p=0.316). 
Additionally, there was no statistically significant change in Ti either with time (p=0.131) 
or with CO2 (p=0.445). Despite no detectable changes in Te or Ti, the Fr response 
remained robust throughout repeated exposures to hypercapnia, and this response did not 
change over time.
3.4 Dose-dependent response
During pilot experiments, it became obvious that 1.5, 3 and 6uM 8-OH-DPAT 
were appropriate doses but that 9uM disrupted the baseline phrenic neurogram to such an 
extent that eupneic bursts were at times difficult to determine. As such, the 9uM dose 
was excluded from subsequent analysis (Figure 16).
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Figure 16. Typical phrenic burst patterns occurring after 8-OH-DPAT treatment. 
Phrenic neurograms are shown under normocapnic conditions, at doses of 1.5, 3 and 
6uM, and the best possible example of burst pattern following a 9uM dose. In most 
cases, burst pattern was difficult to characterize with 9uM treatments. 9uM was 
determined to disrupt the baseline pattern to such an extent that it prohibited statistical 
analysis of the bursts; therefore doses of only 1.5, 3 and 6uM were used in further 
experiments.
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Using a Two-Way ANOVA with time (pre-and post-drug) and dose as factors, we 
found that there were no significant changes with time or with drug dose in: area 
(p=0.924), peak (0.853), Te (0.996) or Ti (0.834), and no interaction between time and 
dose. However, there was a statistically significant difference in Fr before and after 8- 
OH-DPAT (p=0.018). Although this difference in Fr existed before and after treatment, 
there was no difference between the different doses (1.5, 3, and 6uM; excluding sham 
dose) either before or after 8-OH-DPAT treatment (p<0.05), establishing that pooling all 
data from all drug doses was statistically valid. All concentrations of 8-OH-DPAT used 
(1.5, 3, and 6 uM) were sufficient to fully saturate 5- H T ia / b  receptors in the preparation 
(Del Tredici et al. 2004), establishing that pooling between doses is biologically valid.
3.5 Influence of 8-OH-DPAT
Following application of 8-OH-DPAT (pooled between 1.5, 3, and 6uM doses, 
n=13), the burst pattern variables were analyzed under normocapnic conditions. There 
were no significant differences in any of the variables between sham-treated animals and 
animals that received 8-OH-DPAT under normocapnic conditions (using a One-Way 
Repeated Measures ANOVA, comparing the values for Ti, Te, area, peak and Fr all 
presented p>=0.05). 8-OH-DPAT therefore did not affect the “eupneic” burst patterns at 
5% CO2. The perfusate was then changed from 5% CO2 to 7% CO2. Mean values for 
Ti, peak and area were statistically unchanged. When normalized to normocapnic (5% 
CO2) values, the proportional changes in burst pattern variables with hypercapnia were:
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Ti= 1.13 (Figure 16), Te= 0.9 (Figure 17), peak= 0.89 (Figure 18), area-1.02 (Figure 19), 
and Fr= 1.12 (Figure 20). (A change greater than 1 implies an increase in the burst 
pattern variable after hypercapnia; a change of less than one implies a relative decrease in 
hypercapnia). Of these proportional values, only frequency (Fr) and time between bursts 
(Te) differed significantly from 1. The normal increase in frequency (St. John and Paton 
2000) with hypercapnia seen in untreated animals (see initial values section above) was 
abolished after application of 8-OH-DPAT (p=0.028) and a multiple comparison Tukey 
test confirmed this (p=0.029). 8-OH-DPAT abolished the increase in frequency (breaths 
per minute) response to hypercapnia.
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Figure 17. The relative change in the duration of the burst (Ti) following an increase from 
5% to 7% CO2, before and after treatment with 5HTia agonist 8-OH-DPAT. Data are 
mean ± SE for n=6 preparations. A value of 1 implies no change, while values greater 
than 1 show an increase in Ti and less than 1 show a relative decrease in Ti. There was 
no statistically significant difference in Ti (p=1.0) during the normal hypercapnic 
response. The burst duration response was not significantly changed after treatment with 
8-OH-DPAT (p=0.821).
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Figure 18. The relative change in the time between bursts (Te) following an increase 
from 5% to 7% CO2, before and after treatment with 5HT-1A agonist 8-OH-DPAT. Data 
are mean ± SE for n=6 preparations. A value of 1 implies no change, while values 
greater than 1 show an increase in Te and less than 1 show a relative decrease in Te. 
There was a statistically significant reduction in Te (p=<0.001, n=6) during the normal 
hypercapnic response. There was not a statistically significant difference in Te after 
treatment (p=0.073).
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Figure 19. The relative change in burst peak (Peak) following an increase from 5% to 
7% CO2, before and after treatment with 5HT-1A agonist 8-OH-DPAT. Data are mean ± 
SE for n=6 preparations. A value of 1 implies no change, while values greater than 1 
show an increase in peak height and less than 1 show a relative decrease in peak. There 
was no statistically significant difference in peak height (p=1.000, n=6) during the 
normal hypercapnic response. The burst peak height response was not significantly 
changed after treatment with 8-OH-DPAT (p=0.272).
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Figure 20. The relative change in burst area (Area) following an increase from 5% to 7% 
CO2, before and after treatment with 5HT-1A agonist 8-OH-DPAT. Data are mean ± SE 
for n=6 preparations. There was not a statistically significant difference in area 
(p=0.637) during the hypercapnic response. A value of 1 implies no change, while values 
greater than 1 show an increase in frequency, and less than 1 show a relative decrease in 
frequency.
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Figure 21. The relative change in burst frequency (Fr) following an increase from 5% to 
7% CO2, before and after treatment with 5HT-1A agonist 8-OH-DPAT. Data are mean ± 
SE for n=6 preparations. A value of 1 implies no change, while values greater than 1 
show an increase in frequency, and less than 1 show a relative decrease in frequency. 
There was a statistically significant increase in frequency (p=<0.001, n=6) during the 
normal hypercapnic response. The frequency response was significantly reduced (p= 
0.018) following treatment with 8-OH-DPAT, regardless of dose.
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4.0 Conclusion
The respiratory centers located in the medulla and pons are responsible for 
responding to dynamic levels of CO2 and O2 (Richerson 2004). The brain must control 
breathing in a manner that will appropriately compensate for such changes, in order to 
maintain homeostasis. Nattie and Li (2001) showed that efferent respiratory nuclei in the 
medulla and pons have no sensitivity to pH on their own; therefore, a mechanism or link 
must exist that can detect changes in pH and convey this information to the rest of the 
respiratory network (Feldman et al. 2003). One mechanism which may exist is a system 
of chemoreceptive neurons. Respiratory chemoreceptors transmit information about 
changing levels of pH in the blood to the rest of the respiratory control network, thus 
serving to modulate ventilatory responses (Richerson 1995). Several neuron types have 
been proposed as the long-sought “central chemoreceptors” of the medulla, including 
neurons that release serotonin as a neurotransmitter (see Guyenet 2004 and Richerson 
2005 for review).
This study aimed to define the role of serotonin as a modulator of respiration. 
Serotonergic neurons possess the necessary requirements to be effective chemoreceptors: 
they have been shown to be chemosensitive in both in vitro and in vivo preparations 
(Wang et al. 1998, Wang et al. 2001, Richerson 1995, Wang and Richerson 1999,
Bradley et al. 2002, Putnam et a l 2004, Veasey et al. 1995, Bernard et al. 1996) and they 
function in areas of the brainstem that are proximal to arteries, where they could readily 
monitor the acid-base status of blood (Bradley et al. 2002; Severson et al. 2003; Messier
et al. 2004) and they have anatomical connections that would be expected of a 
chemoreceptor, including targets in the brainstem that affect respiratory responses. This 
study tested the hypothesis that brainstem serotonergic neurons are required for 
respiratory sensitivity to CO2 in the perfused rat brainstem preparation.
In order to determine the role of serotonergic neurons in chemosensitivity, this 
study utilized a pharmacological agent (8-OH-DPAT) affecting the serotonergic neurons 
involved in responding to elevated CO2. 8-OH-DPAT, a 5-HTja agonist, selectively 
binds 5-HTia receptors which are often autoreceptors located primarily on cell bodies 
and axon terminals of presynaptic neurons that synthesize and release serotonin (Pauwels 
1997). The result of 5-HTia autoreceptor activation on serotonergic neuron soma is to 
inhibit neuronal firing. 5-HTi a activation at axon terminals inhibits synaptic release of 
serotonin (Lalley et al. 1994). The net result of 8-OH-DPAT application is to reduce or 
remove the influence of serotonergic neurons, thereby preventing the activation of post- 
synaptic neurons that would normally receive serotonergic excitation from these neurons 
(Lalley 1994).
8-OH-DPAT is not known to significantly affect the respiratory motoneurons 
under normocapnic conditions (Taylor et al. 2005). Results from the present study 
indicate that although eupnea persists in the absence of serotonergic modulation, the 
typical chemosensitive response to hypercapnia does not. We abolished the normal 
increase in frequency associated with CO2 exposure after removing the influence of 
serotonergic neurons. These results suggest that serotonergic neurons, although not
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essential for the expression of phrenic burst discharge akin to eupnea, are critical for 
neuroventilatory responses to CO2.
4.1 Eupnea
The perfused rat brainstem preparation produced phrenic nerve discharge 
akin to phrenic discharge during normal spontaneous breathing in vivo (St. John and 
Paton 2000). The bursts had a ramp-like, incrementing shape which is consistent with 
eupneic breathing at normal CO2 levels (St. John and Paton 2000). Burst responses did 
not change over time, and repeated hypercapnic challenges did not affect the subsequent 
normocapnic eupneic breathing pattern. The preparations were consistent among rats. 
Time controls indicated that these preparations produced strong and steady phrenic burst 
patterns well beyond the time required to conduct the experiments, ensuring that the 
protocol could be executed and showing that this experimental preparation provided a 
robust and appropriate means to model respiration.
4.2 Frequency and Te increase with hypercapnia
The hypercapnic response was consistent with accounts from studies that 
suggested only a few of the burst variables would change significantly upon exposure to 
hypercapnic conditions. In initial tests of the perfused rat brainstem preparation, 
respiratory burst frequency and peak tended to increase with hypercapnia (St. John and 
Paton 2000). This is consistent with observations of adult rats in vivo whose respiratory 
frequency tends to increase with rising levels of CO2. When we changed the gas
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equilibrating with the perfusate from 5 to 7% CO2, Fr increased and Te decreased. On 
the other hand, Ti was unchanged. In vivo, many mammalian species tend to breathe at 
higher frequencies during hypercapnia (St. John and Paton 2000, Nattie 2001); the results 
from this study indicated that the perfused rat brainstem preparation exhibits a change in 
ventilatory burst discharge pattern consistent with hypercapnic ventilatory responses of 
intact mammals (St. John and Paton 2000). In sham treatment experiments, repeated CO2 
challenges produced equally robust neuron-ventilatory responses, indicating that the CO2 
response was unchanged over time, and appeared unchanged despite to prior CO2 
exposures.
4.3 Effect of 8-OH-DPAT on burst pattern during normocapnia.
Under normocapnic conditions, phrenic burst discharge pattern was unaffected 
following application of 8-OH-DPAT at any dose (1.5, 3, 6uM). In contrast, the addition 
of 9uM 8-OH-DPAT greatly disrupted baseline eupneic burst pattern such that burst 
variables and their change with CO2 exposure could not be adequately assessed. It is 
possible that introducing a relatively high concentration of agonist had unforeseen side 
effects and implications beyond the respiratory control system with which this study was 
concerned.
4.4 Effect of 8-OH-DPAT on respiratory response
Following ANOVA, it was clear that blocking serotonergic transmission with 8- 
OH-DPAT had no influence on normocapnic burst pattern, but nearly abolished the Fr
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response normally seen in untreated animals exposed to hypercapnia. There were no 
statistically significant differences among different 8-OH-DPAT doses (post hoc Tukey 
test), and the hypercapnic response was significantly affected by 8-OH-DPAT regardless 
of what dose was present.
8-OH-DPAT binds 5HTiA autoreceptors, preventing serotonergic neuron firing 
and inhibiting release of serotonin into the synapse. As such, this treatment prevents 
neurotransmission that would normally activate post-synaptic neurons. These data 
illustrate that abolishing serotonin signaling results in loss of the frequency response to 
hypercapnia. Therefore, serotonergic neurons must play a vital role in modulating the 
respiratory response to CO2.
4.5 Mechanisms
Past research characterized phrenic discharge patterns in the perfused rat 
brainstem as identical to eupnea in vivo (Paton, 1996, St. John and Paton 2000). This 
work has established that the perfused rat brainstem preparation preserves the respiratory 
network responsible for the control of breathing, and therefore, expresses motor patterns 
resembling those of intact animals. Although higher centers are removed, intact tonic 
inputs from pulmonary stretch receptors, chemoreceptors, and carotid bodies are able to 
modify the respiratory response as they would in the intact animal. Thus, use of this 
preparation provides an opportunity to identify the mechanism of neurotransmission 
responsible for generation and modulation of breathing.
Past work (St. John and Paton 2000) and data from the present study suggest that 
the perfused rat brainstem preparation also exhibits changes in burst pattern with 
hypercapnia that are consistent with hypercapnic ventilatory responses in vivo. The 
present study identifies the critical role of serotonergic neurons in producing neuro­
ventilatory responses to hypercapnia and suggests that such mechanisms are also critical 
for ventilatory responses in vivo.
Our experimental results indicate that 8-OH-DPAT treatment did not change 
normal eupneic burst discharge patterns under normocapnic conditions, but abolished the 
increase in phrenic burst frequency that normally occurred in response to hypercapnia in 
this preparation. As such, these results indicate that an 8-OH-DPAT-sensitive 
mechanism is critical for the neuro-ventilatory response to hypercapnia.
8-OH-DPAT binds to the 5-HT]A autoreceptors on the presynaptic cell. 8-OH- 
DPAT treatment inhibits serotonergic neuron activity and inhibits release of serotonin by 
neurons. Both mechanisms prevent serotonergic activation of the post-synaptic cell. As 
8-OH-DPAT treatment abolished changes in phrenic burst pattern normally occurring in 
response to elevated CO2, our results indicate that serotonergic activation is critical for 
neuro-ventilatory response to hypercapnia. These data are consistent with serotonergic 
neurons acting as important chemosensors. Thus, data from this study supports the 
hypothesis that serotonergic neurons are necessary for the expression of hypercapnic 
neuro-ventilatory responses in the perfused brainstem preparation and indicate that such 
neurons could play an important role in CO2 chemosensitivity in vivo.
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